Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the 'real world'?

Giuseppe Boriani¹, Marco Vitolo^{1

2}, Francisco Leyva³

Affiliations

¹ Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
² Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
³ Aston Medical School, Aston University, Birmingham, UK.

Free article

Editorial

Giuseppe Boriani et al. Eur J Heart Fail. 2022 Jul.

Free article

. 2022 Jul;24(7):1223-1226.

doi: 10.1002/ejhf.2581. Epub 2022 Jul 8.

Giuseppe Boriani¹, Marco Vitolo^{1

2}, Francisco Leyva³

¹ Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
² Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
³ Aston Medical School, Aston University, Birmingham, UK.

No abstract available

Comment on

Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.
Schrage B, Lund LH, Benson L, Dahlström U, Shadman R, Linde C, Braunschweig F, Levy WC, Savarese G. Schrage B, et al. Eur J Heart Fail. 2022 Jul;24(7):1212-1222. doi: 10.1002/ejhf.2530. Epub 2022 May 22. Eur J Heart Fail. 2022. PMID: 35502681 Free PMC article.

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322-4.
1. Boriani G, Biffi M, Martignani C, Camanini C, Grigioni F, Rapezzi C, et al. Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs. Eur J Heart Fail. 2003;5:419-25.
1. Goldenberg I, Huang DT, Nielsen JC. The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome. Eur Heart J. 2020;41:2003-11.
1. Boriani G, Biffi M, Martignani C, Diemberger I, Valzania C, Bertini M, et al. Expenditure and value for money: the challenge of implantable cardioverter defibrillators. QJM. 2009;102:349-56.
1. Hess PL, Matlock DD, Al-Khatib SM. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults. Clin Cardiol. 2020;43:187-95.